Definium Therapeutics DFTX
NASDAQ DFTX
$38.09 +0.09 (+0.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Definium Therapeutics (DFTX) Prepaid Assets (2020 - 2026)

Definium Therapeutics (DFTX) posted quarterly Prepaid Assets of $7.1 million for Q1 2026, down 22.88% year-over-year from $9.3 million in Q1 2025, and down 7.58% quarter-over-quarter from $7.7 million in Q4 2025.

Analysis

Definium Therapeutics (DFTX) Prepaid Assets (2020 - 2026) Analysis & Trends

Definium Therapeutics (DFTX) has reported Prepaid Assets for 7 consecutive years, with $7.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets fell 22.88% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $7.1 million (down 22.88% YoY), while the FY2025 annual figure was $7.7 million, down 1.93% from the prior year.
  • Prepaid Assets eased to $7.1 million in Q1 2026 per DFTX's latest filing, from $7.7 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $9.3 million in Q1 2025 and bottomed at $1.8 million in Q3 2022.
  • Historically, Prepaid Assets has averaged $4.8 million across 5 years, with a median of $4.1 million in 2024.
  • Annual changes were most pronounced in 2025 — Prepaid Assets jumped 194.97% — and 2026, when it fell 22.88%.
  • Definium Therapeutics' Prepaid Assets stood at $3.9 million in 2022, then rose by 6.52% to $4.2 million in 2023, then surged by 89.04% to $7.9 million in 2024, then dropped by 1.93% to $7.7 million in 2025, then fell by 7.58% to $7.1 million in 2026.
  • Business Quant data shows DFTX's Prepaid Assets at $7.1 million in Q1 2026, $7.7 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Definium Therapeutics 4.23 Bn 4.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.22 Mn
Mar 31, 2026 7.14 Mn
Dec 31, 2025 7.73 Mn
Sep 30, 2025 6.78 Mn
Jun 30, 2025 6.14 Mn
Mar 31, 2025 9.26 Mn
Dec 31, 2024 7.88 Mn
Sep 30, 2024 4.07 Mn
Jun 30, 2024 4.56 Mn
Mar 31, 2024 3.14 Mn
Dec 31, 2023 4.17 Mn
Sep 30, 2023 2.39 Mn
Jun 30, 2023 2.90 Mn
Mar 31, 2023 3.00 Mn
Dec 31, 2022 3.91 Mn
Sep 30, 2022 1.83 Mn
Jun 30, 2022 3.17 Mn
Mar 31, 2022 2.76 Mn
Dec 31, 2021 3.68 Mn
Dec 31, 2020 1.43 Mn